China

Unlocking Access to Better Hearing Health: New Mobile Fitting Van Hits the Road in China

In a vast and culturally rich nation like China, millions of individuals deserve the opportunity  to experience the beauty of sound. The Signia Mobile...

 September 26, 2023 | News

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...

 September 26, 2023 | News

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Many lung cancer patients are grappling with a multitude of symptoms throughout their treatment process, including but not limited to fatigue, reduced appe...

 September 26, 2023 | News

Chime Biologics Partners with Korea Kings Pharm for Biosimilar Launch

Chime Biologics, a leading CDMO that enables its partners' success in biologics, announced a strategic cooperation with Kings Pharm. According to the agre...

 September 26, 2023 | News

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South...

 September 25, 2023 | News

MediLink Therapeutics Focuses on Advancing ADCs for Cancer Treatment

On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to ...

 September 25, 2023 | News

Golidocitinib Granted Priority Review by China NMPA for the Treatment of r/r PTCL

"Patients with relapsed or refractory PTCL worldwide face limited treatment options and a poor prognosis. We are pleased with the CDE's decision to grant p...

 September 22, 2023 | News

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

 Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to disco...

 September 22, 2023 | News

Lynk Pharmaceuticals Secures 322 Million RMB in Series C2 Funding

This round of financing was jointly participated by the Shaoxing Binhai New Area Biomedical Industry Equity Investment Fund managed by China Grand Prosperi...

 September 22, 2023 | News

Asieris Pharmaceuticals' APL-1702 Achieves Key Milestone in Cervical HSIL Treatment Trial

Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs fo...

 September 21, 2023 | News

WuXi XDC Launches New Commercial Manufacturing Facilities

  New commercial facilities offer one-stop manufacturing services for antibody intermediates, bioconjugate drug substance and drug product Do...

 September 21, 2023 | News

Everest Medicines Collaborates with Kezar Life Sciences to Develop Zetomipzomib in Greater China and other Asian Markets

"We are glad to form a partnership with Kezar through our cooperation on zetomipzomib, which will add to our existing renal pipeline, and help solidify Eve...

 September 21, 2023 | News

China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment

"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...

 September 20, 2023 | News

Cytiva expands scientific, digital, and training offering in China

The facility will host training for more than triple the current number of people per year. The upgraded Fast Trak center will support novel therapy dev...

 September 18, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close